Charles Liles

Charles Liles possesses extensive experience in corporate communications and investor relations, currently serving as the Head, Corporate Communications and Investor Relations at Xencor since September 2018. Prior to this role, Charles held the position of Principal at Decode + Signal for a brief period in 2018 and served as Associate Director, Investor Relations and Corporate Communications at Celldex Therapeutics from May 2015 to June 2018. Charles began career at MacDougall Biomedical Communications as a Senior Account Executive from May 2010 to May 2015 and acquired early experience as an intern at the United States Senate in 2005. Charles earned a Bachelor of Science degree in Business from the Kelley School of Business at Indiana University.